Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16447647 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL1704733 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL16447632 | 0.95 | LMNA (0.36) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL28602862 | 0.95 | LMNA (0.36) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL16447628 | 0.95 | LMNA (0.36) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL2559259 | 0.95 | LMNA (0.36) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL7113425 | 0.86 | LMNA (0.32) | LMNAL3MBTL1TDP1 | |
| SCHEMBL3645857 | 0.81 | LMNA (0.46) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL9344449 | 0.81 | LMNA (0.46) | LMNAL3MBTL1TDP1KDM4EPDE4A | |
| SCHEMBL7118200 | 0.81 | AKR1B1 (0.30) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110215434-A | A kind of Strychnos alkaloid vesicle | 珠海宝德润生健康科技有限公司 | 2019-09-10 | — | — | CN | claimed |
| CN-107753428-A | Adapalene vesica and its preparation and preparation method | 北京盈科瑞创新医药股份有限公司 | 2018-03-06 | — | — | CN | claimed |
| CN-107320716-A | Basic fibroblast growth factor vesica and preparation method thereof | 珠海亿胜生物制药有限公司 | 2017-11-07 | — | — | CN | claimed |
| CN-105748437-A | Vesicle and vesicle preparation, and preparation methods thereof | 北京盈科瑞药物研究院有限公司 | 2016-07-13 | — | — | CN | claimed |
| CN-102579340-B | Sinomenine vesicle and preparation thereof and preparation method | BEIJING INCREASE PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2016-03-02 | — | — | CN | claimed |
| CN-101797239-B | Strychnos alkaloid vesicle and preparation method thereof | BEIJING INCREASE PHARM CO LTD | 2012-09-05 | — | — | CN | claimed |
| CN-102579317-A | Cantharidin vesicles and preparation thereof and preparation methods of cantharidin vesicles and preparation thereof | BEIJING INCREASE PHARM CO LTD | 2012-07-18 | — | — | CN | claimed |
| CN-102579340-A | Sinomenine vesicle and preparation and preparation method thereof | BEIJING INCREASE PHARM CO LTD | 2012-07-18 | — | — | CN | claimed |
| CN-101797239-A | Strychnos alkaloid vesicle and preparation method thereof | BEIJING INCREASE PHARMACEUTICAL TECHNOLOGY CO LTD | 2010-08-11 | — | — | CN | claimed |
| CN-101574319-A | Podophyllotoxin vesicle and preparation method thereof | BEIJING INCREASE PHARM CO LTD (CN) | 2009-11-11 | — | — | CN | claimed |
| CN-101574394-A | Strychnos alkaloid vesicle and preparation method thereof | BEIJING INCREASE PHARM CO LTD (CN) | 2009-11-11 | — | — | CN | claimed |
| EP-0987011-B1 | Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use | OREAL (FR) | 2002-07-17 | — | — | EP | claimed |
| US-6281203-B1 | ESTER OF A FATTY ACID AND GLUCOSE AND/OR ALKYLGLUCOSE, AND AN OXYETHYLENATED ETHER OF A FATTY ACID ESTER OF GLUCOSE AND/OR ALKYLGLUCOSE. | L'OREAL (FR) | 2001-08-28 | — | — | US | claimed |
| EP-0987011-A1 | Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use | L'OREAL (FR) | 2000-03-22 | — | — | EP | claimed |
| EP-0033754-B1 | PROCESS FOR THE HYDROPHILISATION OF SILICON RUBBER CONTACT LENSES | Titmus Eurocon Kontaktlinsen GmbH & Co. KG (DE) | 1984-02-08 | — | — | EP | claimed |
| EP-0033754-A1 | Process for the hydrophilisation of silicon rubber contact lenses | Titmus Eurocon Kontaktlinsen GmbH & Co. KG (DE) | 1981-08-19 | — | — | EP | claimed |
| EP-4395739-A1 | COMPOSITION WITH BIOLOGICALLY ACTIVE AGENT | The Boots Company PLC (GB) | 2024-07-10 | — | — | EP | disclosed |
| CN-117999061-A | Compositions comprising bioactive agents | 布茨公司 | 2024-05-07 | — | — | CN | disclosed |
| EP-0033754-B1 | PROCESS FOR THE HYDROPHILISATION OF SILICON RUBBER CONTACT LENSES | Titmus Eurocon Kontaktlinsen GmbH & Co. KG (DE) | 1984-02-08 | — | — | EP | disclosed |
| EP-0033754-A1 | Process for the hydrophilisation of silicon rubber contact lenses | Titmus Eurocon Kontaktlinsen GmbH & Co. KG (DE) | 1981-08-19 | — | — | EP | disclosed |